Skip to main content
Premium Trial:

Request an Annual Quote

Med Fusion, GenomOncology Partner to Provide Clinical Analyses of Patient Tumors

NEW YORK (GenomeWeb) – Med Fusion and GenomOncology have partnered to provide genomic profiles of patient tumors for treatment guidance and clinical trial enrollment, the companies said today.

Under the agreement, Med Fusion, a clinical service laboratory and clinical trials service organization based in Lewisville, Texas, will combine its solid tumor panels with GenomOncology's GO Clinical Workbench platform, a decision support tool that interprets tumor sequence data and translates molecular profiles into clinical reports.

Med Fusion said it plans to launch several disease-specific solid tumor panels, including for non-small cell lung cancer and colorectal cancer, early in the third quarter.

GenomOncology, located in Cleveland, will use the GO Clinical Workbench to interpret next-generation sequencing data from the tumors, in conjunction with other factors, to create reports and provide rules-based decision support for clinical data interpretation.

"Increased understanding of the underlying genetic changes that may be driving tumor growth or metastasis can enable precise treatment strategies tailored to the genetic profile of each patient's cancer," said Tom Lohmann, chief medical officer of Med Fusion, in a statement.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.